####################
# Output from PRIME (v2.0)
# Alleles: C0304
# Affinity predictions: MixMHCpred (/Users/annieborch/Documents/programs/MixMHCpred-master/MixMHCpred)
# Input file: /Users/annieborch/Documents/IMPROVE/IMPROVE_git/IMPROVE_tool/results/predictions/PRIME/tempPept.txt
#
# PRIME is freely available for academic users.
# Private companies should contact Nadette Bulgin (nbulgin@lcr.org) at the Ludwig Institute for Cancer Research Ltd for commercial licenses.
# To cite PRIME2.0, please refer to:
# Gfeller et al. Predictions of immunogenicity reveal potent SARS-Cov-2 CD8 T-cell epitopes, BioRxiv (2022).
####################
Peptide	%Rank_bestAllele	Score_bestAllele	%RankBinding_bestAllele	BestAllele	%Rank_C0304	Score_C0304	%RankBinding_C0304
LVHGNVCGL	1.246	0.033286	0.866	C0304	1.246	0.033286	0.866
IVTGQVPAV	1.093	0.036702	0.525	C0304	1.093	0.036702	0.525
YSFRGAGLL	1.222	0.033801	0.717	C0304	1.222	0.033801	0.717
